Literature DB >> 22147986

Simultaneous large cell neuroendocrine carcinoma and adenocarcinoma of the stomach.

Tadashi Terada1, Hirotoshi Maruo.   

Abstract

A large cell neuroendocrine carcinoma (LCNEC) of the stomach is very rare. A 76-year-old Japanese man was admitted to our hospital because of epigastralgia and nausea. Endoscopy revealed 2 large tumors in the stomach. He did not have multiple endocrine neoplasia type I or Zollinger-Ellison syndrome. Imaging modalities, including computed tomography and magnetic resonance imaging, revealed no other tumors. Gastrectomy, cholecystectomy, and lymph node dissection were performed. The resected stomach had 2 tumors: one was an antral ulcerated type 3 tumor measuring 5 cm x 5 cm, and the other was a polypoid type 1 tumor measuring 6 cm x 6 cm x 3 cm in the fundus. Microscopically, the antral ulcerated tumor was a well differentiated adenocarcinoma with deep invasion. The fundus polypoid tumor was a LCNEC, being composed of malignant large cells arranged in trabecular and nested patterns. The tumor cells were large and the nuclei were vesicular. Nucleoli were frequently present, and there were many mitotic figures, apoptotic bodies, and necrotic areas. Much lymphovascular permeation was seen. Seven out of 29 dissected lymph nodes showed metastatic foci; 6 were from the LCNEC and 1 from the adenocarcinoma. Many intravascular tumor emboli of LCNEC were seen in the peritoneum around the lymph nodes. Mucins were present in the adenocarcinoma but not in the LCNEC. Immunohistochemically, the LCNEC tumor cells were positive for pancytokeratins, synaptophysin (50% positive), chromogranin A (10% positive), Ki-67 (90% labeled), and platelet-derived growth factor-α (80% positive). They were negative for KIT, p53, CD56, and neuron-specific enolase. The non-cancerous stomach showed a normal number of endocrine cells. The patient is now treated with adjuvant chemotherapy.

Entities:  

Keywords:  Carcinomas; Stomach

Mesh:

Year:  2011        PMID: 22147986      PMCID: PMC3229634          DOI: 10.3748/wjg.v17.i43.4831

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  7 in total

1.  Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth.

Authors:  Tadashi Terada; Masaharu Kawaguchi; Kazuo Furukawa; Yasutomo Sekido; Yoshiyuki Osamura
Journal:  Pathol Int       Date:  2002-11       Impact factor: 2.534

2.  Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.

Authors:  Yoon-Jung Boo; Sung-Soo Park; Jong-Han Kim; Young-Jae Mok; Seong-Joo Kim; Chong-Suk Kim
Journal:  J Surg Oncol       Date:  2007-02-01       Impact factor: 3.454

3.  Primary clear cell adenocarcinoma of the peritoneum.

Authors:  Tadashi Terada; Masaharu Kawaguchi
Journal:  Tohoku J Exp Med       Date:  2005-07       Impact factor: 1.848

4.  Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity.

Authors:  Shi-Xu Jiang; Tetuo Mikami; Atsuko Umezawa; Makoto Saegusa; Toru Kameya; Isao Okayasu
Journal:  Am J Surg Pathol       Date:  2006-08       Impact factor: 6.394

5.  Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants.

Authors:  K Matsui; X M Jin; M Kitagawa; A Miwa
Journal:  Arch Pathol Lab Med       Date:  1998-11       Impact factor: 5.534

6.  Gastric collision tumor of large cell neuroendocrine carcinoma and adenocarcinoma--a case report.

Authors:  Kyu Yun Jang; Woo Sung Moon; Ho Lee; Chan Young Kim; Ho Sung Park
Journal:  Pathol Res Pract       Date:  2009-11-27       Impact factor: 3.250

7.  Incarceration of a large cell neuroendocrine carcinoma arising from the proximal stomach with an organoaxial gastric volvulus through an esophageal hiatal hernia: report of a case.

Authors:  Yukihiro Iso; Nobumi Tagaya; Takehiko Nemoto; Junji Kita; Tokihiko Sawada; Keiichi Kubota
Journal:  Surg Today       Date:  2009-02-07       Impact factor: 2.549

  7 in total
  4 in total

1.  Collision tumour of large-cell neuroendocrine carcinoma and adenocarcinoma in the stomach: A case report.

Authors:  Eduardo Payet; Pau I Pilco; Jaime Montes; Alejandra Cordero-Morales; Maria Jose Savitzky; Karoline Stenning-Persivale
Journal:  Ecancermedicalscience       Date:  2016-01-29

2.  Primary cutaneous neuroendocrine tumor (atypical carcinoid) expressing KIT and PDGFRA with myoepithelial differentiation: a case report with immunohistochemical and molecular genetic studies.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

3.  Gastric adenocarcinoma is concurrent with metastatic neuroendocrine cancer treated with nivolumab and chemotherapy: A case report.

Authors:  Bing Yan; Meiqi Cui; Junhao You; Fang Li; Hui Liu
Journal:  Mol Clin Oncol       Date:  2018-10-05

4.  The Significant Influence of the Neuroendocrine Component on the Survival of Patients with Gastric Carcinoma Characterized by Coexisting Exocrine and Neuroendocrine Components.

Authors:  Hu Ren; Su-Sheng Shi; Nian-Chang Wang; Xing Wang; Ying-Tai Chen; Dong-Bing Zhao
Journal:  J Oncol       Date:  2019-03-12       Impact factor: 4.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.